Font size
WorksheetsNT2 Test
Total questions: 132
Worksheet time: 1hrs 8mins
Growth hormone (GH), human growth hormone (hGH)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Somatomedin C (Insulin-like growth factor or IGF-1)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Magnetic resonance imaging (MRI)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Water deprivation test
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Magnetic resonance imaging (MRI) — thyroid
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Radioactive iodine uptake (RIA)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Calcium (Ca)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Magnetic resonance imaging (MRI) – parathyroid glands
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
C-peptide
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Computed tomography (CT) of the abdomen
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Fasting blood sugar (FBS)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Oral glucose tolerance test (OGTT)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Glycosylated haemoglobin (HbA1C)
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Magnetic resonance imaging (MRI)—pancreas
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Urine tests for glucose and ketone
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
ACTH suppression
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Dexamethasone suppression test
Test for which gland?
Pituitary gland
Thyroid gland
Parathyroid gland
Adrenal gland
Pancreas
Related nursing interventions
• Tell client not to eat or drink 8-10 hours prior to blood test.
• Rest client for 30-60 mins before blood taking.
Growth hormone (GH), human growth hormone (hGH)
Somatomedin C (Insulin-like growth factor or IGF-1)
Magnetic resonance imaging (MRI)
Water deprivation test
Related nursing interventions
• Overnight fasting is preferred but not necessary.
Growth hormone (GH), human growth hormone (hGH)
Somatomedin C (Insulin-like growth factor or IGF-1)
Magnetic resonance imaging (MRI)
Water deprivation test
Related nursing interventions
• Assess for any metallic implants (e.g. pacemaker, clips on brain aneurysms, body piercings).
• Remove transdermal medication patches unless otherwise ordered, replace the patches after the procedure.
• Ask if client is pregnancy.
• Ask about claustrophobia (instruct the client to take relaxing medication prior to the procedure).
Growth hormone (GH), human growth hormone (hGH)
Somatomedin C (Insulin-like growth factor or IGF-1)
Magnetic resonance imaging (MRI)
Water deprivation test
Related nursing interventions
• Instruct client not to smoke, eat, or drink.
• The test takes up to 8 hours.
• Assess weight, take postural BP.
• Assess urine volume and specific gravity, send samples of urine to the lab for osmolality hourly during test.
• Blood samples for osmolality are taken when urine sample are collected and when client demonstrate orthostatic hypotension.
Growth hormone (GH), human growth hormone (hGH)
Somatomedin C (Insulin-like growth factor or IGF-1)
Magnetic resonance imaging (MRI)
Water deprivation test
Related nursing interventions
• Client should not eat or drink for 6-8 hours before the test.
• Instruct client not to take supplemental iodine several weeks before the test and thyroid medications should be discontinued.
• Check for any history of allergy to drug or food.
• Encourage client to increase fluid intake as radionuclide takes 6 – 24 hours to be eliminated from the body.
Radioactive iodine uptake (RIA)
Thyroid antibodies (TA)
Thyroid stimulating hormone (TSH)
Thyroxine (T4)
Triiodothyronine (T3)
Related nursing interventions
• Assess for family history of thyroid disease and assess about recent viral infection (which could trigger autoimmune disease).
Radioactive iodine uptake (RIA)
Thyroid antibodies (TA)
Thyroid stimulating hormone (TSH)
Thyroxine (T4)
Triiodothyronine (T3)
Related nursing interventions
• Instruct client to avoid eating shellfish for several days prior to the test.
• Assess medication: value may be increased by aspirin, steroids; and decreased by lithium and potassium iodide
Radioactive iodine uptake (RIA)
Thyroid antibodies (TA)
Thyroid stimulating hormone (TSH)
Thyroxine (T4)
Triiodothyronine (T3)
Related nursing interventions
• Assess medications as some medications may decreased the level e.g. cortisone, phenytoin, heparin. Values may be increased by oral contraceptives.
Radioactive iodine uptake (RIA)
Thyroid antibodies (TA)
Thyroid stimulating hormone (TSH)
Thyroxine (T4)
Triiodothyronine (T3)
Related nursing interventions
• Assess medications as some medications may decreased the level e.g. Inderal, lithium, phenytoin. Values may be increased by oral contraceptives and methadone.
Radioactive iodine uptake (RIA)
Thyroid antibodies (TA)
Thyroid stimulating hormone (TSH)
Thyroxine (T4)
Triiodothyronine (T3)
Related nursing interventions
• Assess for manifestations of tetany, including positive Chvostek’s and Trousseau’s signs, if hypocalcemia is present.
Calcium (Ca)
Parathyroid hormone (PTH)
Related nursing interventions
• Educate client to fast for 8 hours before the test.
Calcium (Ca)
Parathyroid hormone (PTH)
Related nursing interventions
• Assess for allergy to contrast media.
Computed tomography (CT) of the abdomen
Fasting blood sugar (FBS)
Oral glucose tolerance test (OGTT)
Related nursing interventions
• Not to eat or drink anything other than water for 6 – 8 hours before the test
• Do not administer insulin until blood specimen is taken
• Assess medications: can be increased by cortisone, diuretics, levodopa, epinephrine
Computed tomography (CT) of the abdomen
Fasting blood sugar (FBS)
Oral glucose tolerance test (OGTT)
Related nursing interventions
• Instruct the client to fast for 6-8 hours before the test.
• Assess medications: drugs that increase OGTT level are steroids, oral contraceptives and salicylates
• Explain to the client that he/she may feel weak and may perspire during the test and should report to the nurse.
Computed tomography (CT) of the abdomen
Fasting blood sugar (FBS)
Oral glucose tolerance test (OGTT)
Related nursing interventions
• Encourage patient to take dexamethasone with milk to avoid gastric irritation.
ACTH suppression
Dexamethasone suppression test
Related nursing interventions
• administrated orally at 11pm, as it suppresses ACTH.
• Serum cortisol is collected at 8am the next morning.
ACTH suppression
Dexamethasone suppression test
Thyroid scan
Nonfunctional nodules (malignant lesions) do not take up radioiodine, usually malignant
Cold Spots
Warm Spots
Thyroid scan
Hyperfunctioning nodules (Benign lesions) take up radioiodine
Cold Spots
Warm Spots
Helps to differentiate between type 1 and type 2 diabetes
C-peptide
Fasting blood sugar (FBS)
Oral glucose tolerance test (OGTT)
Glycosylated haemoglobin (HbA1C)
Urine tests for glucose and ketone
a clinical condition that results from increased thyroid hormone production
Thyrotoxicosis
Hyperthyroidism
Over-activity of the thyroid gland with sustained increase in synthesis and release of TH
Thyrotoxicosis
Hyperthyroidism
What is the name of the disease that causes:
⚪ Graves’ disease
⚪ Toxic adenoma, toxic multinodular goitre
⚪ Thyroiditis: subacute thyroiditis, Hashimoto’s thyroiditis
⚪ Iatrogenic: overtreatment with TH; iodine induced (drugs [e.g. amiodarone], contrast media)
⚪ Pituitary disorders: TSH-secreting pituitary tumour; pituitary thyroid hormone resistance
(a)
Laboratory Test
decreased TSH
Graves’ disease
Pituitary adenoma
Laboratory Test
increased TSH
Graves’ disease
Pituitary adenoma
Laboratory Test
thyrotropin-receptor antibodies (TRAb): highly sensitive and specific, positive in 95% of patients with?
Graves’ disease
Pituitary adenoma
Management of Hyperthyroidism
⚪ Thionamides : carbimazole, methimazole/thiamazole, levothyroxine, propylthiouracil (PTU)--> Inhibit synthesis of TH
⚪ Do not affect the release or activity of TH that has been formed--> treatment should continue for 12 to 18 months
⚪ Initially at higher doses and titrated to lower maintenance doses
⚪ Methimazole is contraindicated in pregnancy (cross placenta)
Antithyroid Drug (ATD)
Beta-blockers
Management of Hyperthyroidism
⚪ Symptomatic therapy
⚪ Competitively block β-adrenergic receptors
⚪ Controls tachycardia and other cardiac symptoms of thyrotoxicosis (e.g. palpitation) that results from -> β -adrenergic receptor stimulation caused by excessive TH
⚪ Primary options: propranolol or atenolol
⚪ Secondary options: diltiazem or verapamil
⚪ Propranolol may also inhibits peripheral conversion of T4 to T3
⚪ Not indicated if there is history of asthma, bradycardia, or heart block
⚪ Calcium-channel blockers are an alternative if this are contraindicated
Antithyroid Drug (ATD)
Beta-blockers
Postoperative Complications of Hyperthyroidism
Nursing Responsibilities:
⚫ Closely monitor vital signs including blood pressure and pulse hourly to monitor for manifestations of hypovolemic shock
⚫ Elevate the head of bed with pillows to reduce oedema
⚫ Assess dressing and the area under the client’s neck and shoulders for early detection of haemorrhage
⚫ Monitor the drainage volume, consistency and colour for signs of increased bleeding
⚫ Ensure patency of wound drainage system
⚫ Monitor for neck swelling, sensation of fullness at neck for early detection of respiratory difficulty
Haemorrhage and Haematoma
Respiratory Distress
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Postoperative Complications of Hyperthyroidism
Nursing Responsibilities:
⚫ Position client at a semi-Fowler’s position to minimize oedema at surgical site and facilitate breathing
⚫ Prepare the suction equipment, oxygen, and a tracheostomy set available for emergency use
⚫ Assess for:
⚪ Respiratory rate , rhythm, effort and SpO2
⚪ Manifestations of airway obstruction: swelling/ sensation of pressure or fullness at neck, laryngeal stridor and difficulty in swallowing
⚪ Signs of hypoxia: dyspnoea, tachypnoea, altered mental state, cyanosis
⚪ Wound drain for the amount and consistency of drainage for excessive collection of blood
⚪ Wound dressing for bleeding and neck swelling/tightness indicative of oedema, internal bleeding or haematoma
Haemorrhage and Haematoma
Respiratory Distress
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Postoperative Complications of Hyperthyroidism
Nursing Responsibilities:
● Assess voice quality, tone, ability to speak aloud and difficulty in breathing to detect RLN injury
● Keep communication with client simple to minimize demand for response and promote voice rest
• Anticipate needs as much as possible to reduce anxiety and client's needs to communicate
• Maintain quiet environment to enhance ability to hear whispered communication
● Provide alternative methods of communication (e.g. writing) to facilitate expression of needs
● Inform doctor immediately for breathing difficulty and intervene promptly
● If there is an obvious respiratory distress with vocal cord paralysis confirmed, emergency tracheostomy may be done to create an open airway
● If there is functional palsy, the condition may recover within 3 - 6 months
● If there is structural damage, plastic repair of vocal cords will be required, then followed with speech therapy
Haemorrhage and Haematoma
Respiratory Distress
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Postoperative Complications of Hyperthyroidism
Nursing Responsibilities:
● Assess for any complaints of numbness or tingling in fingers and toes and muscular twitches
● Observe for laryngeal stridor for early recognition and prompt intervention
● Monitor client for positive Trousseau’s sign and Chvostek’s sign suggestive of hypocalcaemia
● Monitor postoperative serum calcium level to detect hypocalcaemia
● Keep calcium gluconate or calcium chloride available for immediate IV use to reverse hypocalcaemia
Haemorrhage and Haematoma
Respiratory Distress
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Postoperative Complications of Hyperthyroidism
Nursing Responsibilities:
● Monitor client’s vital signs for increase body temperature, blood pressure and pulse, respiratory rate which may be indicative of thyroid storm
● Observe for complaints of feeling hot, palpitation
● Observe client’s mental state and any periods of agitation, confusion to detect signs of thyroid storm
● Report to surgeon immediately if these symptoms occurs and implement interventions promptly
Haemorrhage and Haematoma
Respiratory Distress
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Haemorrhage and Haematoma
Can be evacuated by needle aspiration
Small and Stable Haematoma
Expanding Haematoma
Haemorrhage and Haematoma
⚪ Difficulty in breathing, pressure in the neck, voice change and obvious collection in wound
⚪ Requires emergent surgical intervention
Small and Stable Haematoma
Expanding Haematoma
Clinical Manifestations
● Unilateral injury: weak, hoarseness of voice
● Bilateral injury: aphonia, respiratory distress with increasing dyspnoea and stridor
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Clinical Manifestations
⚫ Restlessness
⚫ Numbness and tingling sensation over face, hands and feet
⚫ Spasm of facial muscle, carpopedal spasm
⚫ Spasm of vocal cords and bronchus : high-pitch voice, airway obstruction, suffocation
⚫ Positive Chvostek’s sign
⚫ Positive Trousseau’s sign
⚫ Hypocalcaemia (< 8 mg/dL)
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Clinical Manifestations
● Abrupt onset of extreme agitation, confusion, tachycardia or other arrhythmia
Recurrent Laryngeal Nerve (RLN) Injury
Tetany (Hypoparathyroidism)
Thyroid Storm
Tetany (Hypoparathyroidism)
⚪ Impaired blood supply to the parathyroid glands after surgery
Transient Hypocalcaemia
Permanent Hypocalcaemia
Tetany (Hypoparathyroidism)
⚪ Compromise of all parathyroid glands (accidental removal of parathyroid glands)
Transient Hypocalcaemia
Permanent Hypocalcaemia
Elicitation: Tapping on the face at a point just anterior to the ear and just below the zygomatic bone
Positive response: Twitching of the ipsilateral facial muscles, suggestive of neuromuscular excitability caused by hypocalcaemia
(a)
Elicitation: Inflating a sphygmomanometer cuff above systolic blood pressure for several minutes
Positive response: Muscle contraction including flexion of the wrist and metacarpophalangeal joints, hyperextension of the fingers, and flexion of the thumb on the palm, suggestive of neuromuscular excitability caused by hypocalcaemia
(a)
Structure of the Parathyroid Glands
PTH secretion (?) when plasma calcium level fall
increases
decrease
Structure of the Parathyroid Glands
By increasing renal excretion of phosphate in urine, (?) excretion of calcium, (?) bone reabsorption to cause release of calcium from bones.
decreasing, increasing
increasing, decreasing
• parathyroid adenoma (95%)
• parathyroid hyperplasia, parathyroid carcinoma, external neck irradiation, Lithium therapy
Primary (1o ) Hyperparathyroidism
Secondary (2o ) Hyperparathyroidism
Tertiary Hyperparathyroidism
• A reaction of parathyroid glands (compensatory oversecretion of PTH) to hypocalcaemia, e.g. chronic kidney (CKD) disease, pregnancy, vitamin D deficiency etc.
Primary (1o ) Hyperparathyroidism
Secondary (2o ) Hyperparathyroidism
Tertiary Hyperparathyroidism
⚪ It results from hyperplasia of parathyroid glands and a loss of response to serum calcium level, commonly seen in chronic kidney disease.
Primary (1o ) Hyperparathyroidism
Secondary (2o ) Hyperparathyroidism
Tertiary Hyperparathyroidism
ECG 1 small box or 1mm = (?) second
0.5
0.20
0.04
0.1
ECG 1 large box or 5mm = (?) second
0.5
0.20
0.04
0.1
ECG
Time and voltage measurements on ECG paper at a recording speed of (?) mm/second
25
20
0.5
0.20
Descriptions: indicates atrial depolarization and contraction.
Normal value: Round and upright
What is the wave form
P wave
QRS complex
T wave
U wave
Descriptions: indicates ventricular depolarization and contraction.
Normal value: 0.06-0.10 second
What is the wave form
P wave
QRS complex
T wave
U wave
Descriptions: indicate ventricular repolarization following contraction.
Normal value: Less than 10mm tall
What is the wave form
P wave
QRS complex
T wave
U wave
Descriptions: Signify repolarization of the terminal Purkinje fibers.
Normal value: Not normally seen
What is the wave form
P wave
QRS complex
T wave
U wave
Descriptions: indicates the time for sinus impulse transmitting to AV node and Purkinje fibers.
Normal value: 0.12-0.20 second
What is the wave form
PR interval
ST segment
QT interval
Descriptions: signifies the beginning of ventricular repolarization.
Normal value: Isoelectric line
What is the wave form
PR interval
ST segment
QT interval
Descriptions: Indicates the total time of ventricular depolarization and repolarization.
Normal value: 0.21-0.44 second
What is the wave form
PR interval
ST segment
QT interval
Ambulatory Cardiac Monitoring:
Clients are instructed to keep the electrodes in place and record any cardiac symptoms and events during the prescribed period, usually (?) hours for analysis.
24-48
48-72
36-48
24-72
To evaluate the response of the cardiovascular system to the stress induced by exercise or drugs.
Holter monitoring
Cardiac Stress Test (Treadmill)-ECG
Echocardiography (Echo)
Transesophageal echocardiography (TEE)
A transducer is used to record the high- frequency sound waves bounced off the heart to assess direction and flow of blood through heart in audio and graphic data.
Holter monitoring
Cardiac Stress Test (Treadmill)-ECG
Echocardiography (Echo)
Transesophageal echocardiography (TEE)
Allows visualization of adjacent cardiac and extracardiac structure to identify or monitor mitral
and aortic valve pathology, left atrium intracardiac thrombus, acute dissection of the aorta,
endocarditis, perioperative left-ventricular function and intracardiac repairs during surgery
Holter monitoring
Cardiac Stress Test (Treadmill)-ECG
Echocardiography (Echo)
Transesophageal echocardiography (TEE)
Use computer-processed combinations of many X- ray images to visualize the heart anatomy,
coronary circulation, or to quantify early calcium deposits in coronary arteries (calcium score)
Computed Tomography (CT) Coronary Angiography
Single-Photon Emission Computed
Tomography (SPECT)
MUGA Scan
Positron Emission Tomography (PET) Scan
Cardaic Magnetic Resonance Imaging
(MRI)
Use for evaluation of myocardium as risk of infarction and to determine infarction size
Intravenous administer radioisotopes and detected by gamma or scintillation camera
Computed Tomography (CT) Coronary Angiography
Single-Photon Emission Computed
Tomography (SPECT)
MUGA Scan
Positron Emission Tomography (PET) Scan
Cardaic Magnetic Resonance Imaging
(MRI)
For evaluation of pumping function:
◦ cardiac status following MI and congestive heart failure
◦ effectiveness of cardiac medications
◦ left ventricular function during rest and exercise
Computed Tomography (CT) Coronary Angiography
Single-Photon Emission Computed
Tomography (SPECT)
MUGA Scan
Positron Emission Tomography (PET) Scan
Cardaic Magnetic Resonance Imaging
(MRI)
◦ The resulting images are compared for myocardial perfusion and myocardial metabolic function
Computed Tomography (CT) Coronary Angiography
Single-Photon Emission Computed
Tomography (SPECT)
MUGA Scan
Positron Emission Tomography (PET) Scan
Cardaic Magnetic Resonance Imaging
(MRI)
◦ Use magnetic field and computer-generated pictures to image the heart and great vessels so as to identify the areas of MI, perfusion of the heart and patency of coronary arteries after coronary grafts and to evaluate pericarditis and cardiac tumors
◦ Assess for any metallic implant such as pacemaker, prosthetic joints, or clips.
Computed Tomography (CT) Coronary Angiography
Single-Photon Emission Computed
Tomography (SPECT)
MUGA Scan
Positron Emission Tomography (PET) Scan
Cardaic Magnetic Resonance Imaging
(MRI)
QRS < 120ms
Narrow complex
Wide complex
QRS > 120ms
Narrow complex
Wide complex
• Rhythm: Regular
• Rate: 60-100/min
• P wave: 0.08-0.10s
• P:QRS : 1:1
• PR interval: 0.12-0.20s (< 0.20 sec)
• QRS complex: 0.06-0.10s
Normal sinus rhythm (NSR)
Sinus bradycardia
Sinus tachycardia
• Rhythm: Regular
• Rate: < 60/min
• P:QRS : 1:1
• PR interval : 0.12- 0.20 sec
• QRS complex: 0.06-0.10s
Normal sinus rhythm (NSR)
Sinus bradycardia
Sinus tachycardia
• Rhythm: Regular
• Rate: 101-150/min
• P:QRS : 1:1 (with very fast rates, P wave may be hidden in preceding T waves)
• PR interval: 0.12-0.2s
• QRS complex: 0.06-0.10s
Normal sinus rhythm (NSR)
Sinus bradycardia
Sinus tachycardia
Atrial dysrhythmias:
• Rate: Variable
• Rhythm: irregular, normal rhythm interrupted by early beats arising from atrial, P waves are premature and differ from normal sinus P
wave
• P:QRS : 1:1
• PR interval: 0.12-0.2s, but may be prolonged
• QRS complex: 0.06-0.10s
Premature atrial contraction (PAC)
Atrial flutter
Atrial Fibrillation
Atrial dysrhythmias:
• Atrial rate: 240-360/min (Intra-atrial reentry mechanism)
• Rhythm: atrial regular; ventricular usually irregular;
• Identical recurring regular sawtooth flutter waves
• P:QRS : 2:1, 3:1 or 4:1 (ratio between flutter wave and QRS complex)
• QRS complex: 0.06-0.10s
• Commonly occurs in association with
– Chronic obstructive pulmonary disease (COPD)
– Pulmonary hypertension
– Coronary artery disease (CAD)
– Valvular disease
– Thyrotoxicosis
Premature atrial contraction (PAC)
Atrial flutter
Atrial Fibrillation
Atrial dysrhythmias:
• Rate: atrial rate 350-600/min, absent of P wave
• Multifocal ectopic foci in atria without effective atrial contraction
• Rhythm: Irregular
• P:QRS : Variable, ventricular rhythm is very irregular ranges from 100-180/min
• QRS complex: 0.06-0.10s
Premature atrial contraction (PAC)
Atrial flutter
Atrial Fibrillation
• Rhythm: Regular
• Rate: fast, 100-280/min; usually >150/min
• Absent of P wave
• umbrella term for rhythms originate above ventricles. P wave usually not measurable, and mechanism not known
• PR interval difficult to detect
• QRS present, narrow, unifocal
Supraventricular tachycardia (SVT)
Junctional rhythm
Sick sinus syndrome (SSS)
– P wave is inverted, absent, buried, retrograde in some of the ECG leads
– PR interval < normal (<0.12 sec)
– QRS complex is typically narrow
Supraventricular tachycardia (SVT)
Junctional rhythm
Sick sinus syndrome (SSS)
• Sinus node dysfunction influences impulse formation, transmission, conduction
• Common in older adults
• Sinus bradycardia, sinus arrhythmia, sinus pauses or arrest and atrial tachyarrhythmias
• Bradycardia-tachycardia syndrome
Supraventricular tachycardia (SVT)
Junctional rhythm
Sick sinus syndrome (SSS)
• Impulse conduction through the AV node is slowed, but all impulses are conducted
• Benign condition → asymptomatic → treatment not required
• May be a result of digitalis or structural abnormalities
• Prolonged PR interval (PRI) but constant
First-degree AV block (1 AVB)
Second-degree Type I
(Mobitz I or Wenckebach)
Second-degree Type II AV block (Mobitz II)
Third-degree AV block
(Complete heart block / CHB)
• A block in AV node
• QRS are “grouped” into twos, threes, fours
• Repeating pattern of increasing AV conduction delays until an impulse fails to conduct to the ventricles
• Ventricle rate remains adequate
➢Progressive lengthening of PR interval until an entire cycle is dropped
First-degree AV block (1 AVB)
Second-degree Type I
(Mobitz I or Wenckebach)
Second-degree Type II AV block (Mobitz II)
Third-degree AV block
(Complete heart block / CHB)
• Intermittent failure of the AV node to conduct an impulse to the ventricles without preceding delays in conduction.
• PR interval remains constant, but not all P followed by QRS complex
• Ratio of P:QRS → e.g. 2:1, 3:1, 4:1
• Associated with MI, drug toxicity, congenital, valvular disease, hyperkalemia
• Treatment: pharmacological and electrical therapy
First-degree AV block (1 AVB)
Second-degree Type I
(Mobitz I or Wenckebach)
Second-degree Type II AV block (Mobitz II)
Third-degree AV block
(Complete heart block / CHB)
• It occurs when atrial impulses are completely blocked at the AV node and fail to reach the ventricles.
• Complete dissociation of impulse between atria and ventricles
➢(No relationship between P waves and QRS complexes)
First-degree AV block (1 AVB)
Second-degree Type I
(Mobitz I or Wenckebach)
Second-degree Type II AV block (Mobitz II)
Third-degree AV block
(Complete heart block / CHB)
• Beats arise from the same focus all QRSs look alike
• Regular
• Fast
• No P
• Wide-complex
• Beats arise from the same focus therefore all QRS look alike
Monomorphic VT
Ventricular fibrillation (VF)
Pulseless electrical activity (PEA)
Asystole
• Rapid, disorganized ventricular rhythm that causes ineffective quivering of the ventricles due to extremely chaotic ventricular depolarization → no CO.
Monomorphic VT
Ventricular fibrillation (VF)
Pulseless electrical activity (PEA)
Asystole
• Cardiac conduction impulses occur in an organised pattern but ineffective contractions
• Looks like NSR
• no CO and no pulse
Monomorphic VT
Ventricular fibrillation (VF)
Pulseless electrical activity (PEA)
Asystole
· Predictable and caused by similar precipitating factors each time, e.g., exercise, emotional upset, being in very cold temperature, smoking, heavy meals and tachycardia.
· Relieved by rest and Nitrates (sublingual TNG)
Stable angina
Prinzmetal’s (variant) angina
Unstable angina
Microvascular angina
Refactory angina
· Atypical angina and unpredictable and often at night
· Caused by coronary artery spasm
Stable angina
Prinzmetal’s (variant) angina
Unstable angina
Microvascular angina
Refactory angina
· Unpredictable increasing frequency, severity, and duration of pain, may occur at rest
· May not relieved by rest and Nitrate (3 sublingual TNG tablets)
Stable angina
Prinzmetal’s (variant) angina
Unstable angina
Microvascular angina
Refactory angina
· Affects the smallest coronary artery blood vessels
· Usually lasts more than 15 – 20 minutes
Stable angina
Prinzmetal’s (variant) angina
Unstable angina
Microvascular angina
Refactory angina
· long-term chest pain doesn’t get better with medication and surgery
Stable angina
Prinzmetal’s (variant) angina
Unstable angina
Microvascular angina
Refactory angina
Types of AMI:
Subendocardial infarction
Non-ST segment elevation myocardial infarction (NSTEMI)
ST-Elevation Myocardial Infarction (STEMI)
Types of AMI:
Transmural infarction
Non-ST segment elevation myocardial infarction (NSTEMI)
ST-Elevation Myocardial Infarction (STEMI)
GENERAL MANAGEMENT, Unstable angina/NSTEMI/NSTE-ACS:
- Aspirin,
- P2Y12 inhibitors include prasugrel (Effient), ticagrelor (Brilinta) and clopidogrel (Plavix)
- Low-Molecular-Weight-Heparin (LMWH) e.g. Enoxaparine (Clexane)
Antithrombotic therapy
Anti-ischaemic therapy
GENERAL MANAGEMENT, Unstable angina/NSTEMI/NSTE-ACS:
I. Nitrates
II. Beta-blockers
III.Calcium Antagonists
Antithrombotic therapy
Anti-ischaemic therapy
Rhythms for Tachycardia:
• Narrow-QRS complex (SVT) tachycardias (QRS less than 0.12 s) in order of frequency (≥150bpm)
• Sinus tachycardia
• Atrial fibrillation
• Atrial flutter etc
• Monomorphic VT
• Polymorphic VT
• Regular or irregular tachycardias
Rhythms for Tachycardia:
• Wide-QRS complex tachycardia (QRS 0.12 s or more)
• Sinus tachycardia
• Atrial fibrillation
• Atrial flutter etc
• Monomorphic VT
• Polymorphic VT
• Regular or irregular tachycardias
Stable Tachycardia:
QRS <0.12 (Narrow) and Regular
Attempt?
Vagal maneuvers
Adenosine
Bradycardia Management:
Unstable bradycardia
Administrate?
Vagal maneuvers
Adenosine
Atropine
ACLS related pharmacological therapy:
Mechanisms of action: Binds with alpha- and beta- adrenergic receptors, increasing heart rate and force of contraction, causing vasoconstriction and relaxing bronchial smooth muscle
Dosage: Cardiac arrest:
• IV/IO: 1mg (in 10 mL) of 1:10000 solution IV push, follow with 20 mL fluid flush, may repeat 1 mg dose every 3 to 5 min
• Tracheal: 2 to 2.5 mg diluted in 5 to 10 mL of sterile water or normal saline
Considerations: available in different concentrations
Adrenaline
Dopamine
Atropine
ACLS related pharmacological therapy:
Action:
· Causes increased cardiac output
· Acts on beta 1 and alpha receptors causing vasoconstriction in blood vessels
· Low dose causes renal and mesenteric vasodilation
· Beta 1 stimulation produces inotropic effects with increased cardiac output
Uses: Shock, increase perfusion, hypotension, bradycardia
Dosages & Route: IV infusion, 5-10 mcg/kg/min, maximum 50 mcg/kg/min
Adrenaline
Dopamine
Atropine
ACLS related pharmacological therapy:
Action:
• Blocks acetylcholine at parasympathetic neuroeffector sites
• Increases cardiac output and heart rate and blocking vagal stimulation
Uses: Bradycardia, bradyarrhythmia, cardiac vagal reflexes
Adrenaline
Dopamine
Atropine
LABORATORY STUDIES
Examination of the client’s (?) and (?) can provide information about a primary musculoskeletal problem
blood, urine
blood, bone
bone, urine
blood, bone
LABORATORY STUDIES
• This enzyme, produced by osteoblasts of bone, is needed for mineralization of organic bone matrix
• Increased in bone cancer, healing fractures, rheumatoid arthritis and osteoporosis
• Normal value: 42-136 U/L
Alkaline phosphatase (ALP)
Acid phosphatase
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
• is one of a group of enzymes located primarily in the prostate gland and prostatic secretions.
Smaller amounts are found in bone marrow
• Increased in bone fracture, cancer with bone metastasis
• Normal value: 0.5 -2.0 U/L
Alkaline phosphatase (ALP)
Acid phosphatase
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
■ To monitor calcium levels and detect calcium imbalances
■ provides bone with rigid structure
■ decrease serum level is found in osteomalacia, renal disease, and hypoparathyroidism
■ increase in bone cancer and multiple fractures
■ Normal value: 4.5- 5.5 mEq/L
Alkaline phosphatase (ALP)
Acid phosphatase
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
■ is formed as the purines adenine and guanine are continuously metabolized during the formation and degradation of RNA and DNA and from metabolism of dietary purines
■ increase in gout
■ Normal value: 2.8- 6.8 mg/dL (females)
3.5– 8.0 mg/dL (males)
Alkaline phosphatase (ALP)
Acid phosphatase
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
■ is an immunoglobulin present in the serum of 50%-95% of adults with rheumatoid arthritis (RA)
■ Also increased in lupus erythematosus and scleroderma
■ Normal value: < 1:20 titer
Alkaline phosphatase (ALP)
Acid phosphatase
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
■ are glycoproteins found on all nucleated cells
■ The presence of B-27 antigen is highly correlated with ankylosing spondylitis and rheumatoid arthritis
■ Normal value: negative
Leukocyte antigen (HLA)-B27
Bence Jones Protein (Urine)
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
LABORATORY STUDIES
■ A low-molecular-weight, light-chain immunoglobulin synthesized by malignant plasma cells in the bone marrow and
initially broken down and reabsorbed by the kidneys
■ Positive: in osteomalacia
■ Normal value: negative
Leukocyte antigen (HLA)-B27
Bence Jones Protein (Urine)
Serum calcium (Ca)
Serum uric acid
Rheumatoid factor (RF)
The common bacteria in septic arthritis includes:
1. Staphylococcus aureus
2. Neisseria gonorrhoeae
1
2
1, 2
The common bacteria in osteomyelitis includes:
1. Staphylococcus aureus
2. Neisseria gonorrhoeae
1
2
1, 2
Classification of Necrotizing Fasciitis
■ Polymicrobial, usually combinations of anaerobes and Enterobacteriaceae species
■ Usually in occurs in immunocompromised individuals, such as clients with DM, peripheral vascular disease, post surgery or trauma, intravenous drug users
■ More likely to be present on the trunk, abdomen, perineum, or perianal
Type I
Type II
Gas gangrene/ Type III
Variant of Type I
Classification of Necrotizing Fasciitis
■ Monomicrobial and caused by Group A β-hemolytic streptococci (GABHS) related ± Staphylococci (Meticillin- Sensitive Staphylococcus aureus (MSSA) or methicillin– resistant Staphylococcus aureus (MRSA))
■ Usually in clients with surgery, minor trauma or varicella; 50% do not have an obvious portal of entry
■ Common on the head and neck, and limbs
Type I
Type II
Gas gangrene/ Type III
Variant of Type I
Classification of Necrotizing Fasciitis
■ Caused by Clostridium perfringen, C. septicum or C histolyticum (gas- producing organisms)
■ Always have an obvious portal of entry
■ Usually in patients with surgery, trauma or colonic cancer or leukemia
Type I
Type II
Gas gangrene/ Type III
Variant of Type I
Classification of Necrotizing Fasciitis
■ Also called saltwater NF
■ Caused by Vibrionaceae, including Vibrio (e.g. Vibrio vulnificus), Aeromonas (e.g. Aeromonas hydrophilia) and Plesiomonas
■ Usually in clients with minor trauma and exposure to river or sea water
■ Vibrio vulnificus infection is considered as one of the “communicable diseases of topical public health concern” should be notified to the Centre for Health Protection (CHP)
Type I
Type II
Gas gangrene/ Type III
Variant of Type I
Clinical Manifestations of Necrotizing Fasciitis
• Warm on palpation
• Erythema
• Tenderness to palpitation (extending beyond apparent areas of skin involvement)
• Swelling
• Pain out of proportion to the swelling or erythema
• Fever
• Tachycardia
Early Phase
Late Phase
Clinical Manifestations of Necrotizing Fasciitis
• Vesicle or bullae formation
• Skin fluctuance
• Skin induration
• Pus or foul smell discharge
• Crepitus
• Skin necrosis with dusky discolouration progressing to frank gangrene
• Severe pain or skin anaesthesia due to cutaneous infarct
• Hypotension
• Shock
• Multiple organs failure
Early Phase
Late Phase
